Literature DB >> 8678331

Peripheral neuropathy associated with ischemic vascular disease of the lower limbs.

F Laghi Pasini1, M Pastorelli, U Beermann, S de Candia, S Gallo, P Blardi, T Di Perri.   

Abstract

This paper deals with the possible identification of somatic and autonomic nerve damage in patients with peripheral obliterative arterial disease (POAD) at different stages of the disease, with a well-reproducible technique like electroneurographic evaluation of nerve conduction. In 64 patients with intermittent claudication, 19 patients with pain at rest, and 7 patients with trophic ulcers, electroneurographic evaluation of motor (tibial and peroneal) and sensory (superficial peroneal and sural) nerve conduction was performed. The median nerve (motor and sensory) was used as control. A severe impairment of sural and superficial peroneal nerve velocities was evident in many claudicant patients and in all patients with pain at rest and trophic ulcers, with a progression in the conduction abnormalities in advanced stages of the disease. Motor nerve conduction showed only minor reductions in patients with claudication and pain at rest, although some of them did show very poor velocity values. In 21 patients with intermittent claudication and sensory nerve abnormalities, the autonomic fibers activity, evaluated by the skin sympathetic response (SSR) test, was significantly depressed, thus suggesting an involvement of the local autonomic system in the ischemic disease. A correlation exists between the severity of the somatic nerve damage and the stage of the vascular insufficiency. However, in the group of claudicant patients, the evidence of similar ischemic threshold (claudication distance) may be associated with a marked difference in the amount of somatic nerve damage. The somatic and autonomic nerve alterations may play a relevant role in the progression of the disease toward critical limb ischemia.

Entities:  

Mesh:

Year:  1996        PMID: 8678331     DOI: 10.1177/000331979604700605

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  14 in total

1.  Pharmacological treatment of intermittent claudication does not have a significant effect on gait impairments during claudication pain.

Authors:  Jennifer M Yentes; Jessie M Huisinga; Sara A Myers; Iraklis I Pipinos; Jason M Johanning; Nicholas Stergiou
Journal:  J Appl Biomech       Date:  2012-05       Impact factor: 1.833

Review 2.  Diabetic neuropathy in older adults.

Authors:  Aaron I Vinik; Elsa S Strotmeyer; Abhijeet A Nakave; Chhaya V Patel
Journal:  Clin Geriatr Med       Date:  2008-08       Impact factor: 3.076

3.  4-Phenylbutyric acid protects against vasculitic peripheral neuropathy induced by ischaemia-reperfusion through attenuating endoplasmic reticulum stress.

Authors:  Cay-Huyen Chen; Ping-Chen Shih; Han-Yu Lin; Po-Kai Wang; Po-Ting Pan; Ching-Wei Chuang; Ming-Chang Kao
Journal:  Inflammopharmacology       Date:  2019-05-22       Impact factor: 4.473

4.  Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.

Authors:  F-L Liu; C-S Lin; C-C Yeh; C-C Shih; Y-G Cherng; C-H Wu; T-L Chen; C-C Liao
Journal:  Osteoporos Int       Date:  2017-08-18       Impact factor: 4.507

5.  Vascular factors predict polyneuropathy in a non-diabetic elderly population.

Authors:  Marzia Baldereschi; Marco Inzitari; Antonio Di Carlo; Francesca Bovis; Stefania Maggi; Antonio Capurso; Vincenzo Solfrizzi; Francesco Panza; Emanuele Scafato; Domenico Inzitari
Journal:  Neurol Sci       Date:  2012-08-15       Impact factor: 3.307

6.  Is cardiovascular disease a risk factor in the development of axonal polyneuropathy?

Authors:  L L Teunissen; H Franssen; J H J Wokke; Y van der Graaf; W H J P Linssen; J D Banga; D M Laman; N C Notermans
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-05       Impact factor: 10.154

7.  Predictors of walking capacity in patients with peripheral arterial disease.

Authors:  Hazal Yakut; Didem Karadibak; Sadık Kıvanç Metin; Dündar Özalp Karabay; Tuğra Gençpınar
Journal:  Wien Klin Wochenschr       Date:  2022-09-08       Impact factor: 2.275

8.  [Correlation between quantitative sensory testing and questionnaires on neuropathic pain for chronic ischemic pain in peripheral arterial disease].

Authors:  P M Lang; L J Rüger; T Abahji; U Hoffmann; A Crispin; D Irnich
Journal:  Schmerz       Date:  2009-06       Impact factor: 1.107

9.  [Therapy of chronic ischemic pain in peripheral arterial disease. A survey among physicians].

Authors:  L J Rüger; D Irnich; S Grasmueller; P M Lang
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

Review 10.  Parallels between the Developing Vascular and Neural Systems: Signaling Pathways and Future Perspectives for Regenerative Medicine.

Authors:  Idoia Elorza Ridaura; Stefano Sorrentino; Lorenzo Moroni
Journal:  Adv Sci (Weinh)       Date:  2021-10-24       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.